Drug intelligence / Profile preview

Tonglin Guben

Development stage: Preclinical
Modality: Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration: Oral

Overview

Tonglin Guben is a traditional Chinese medicine (TCM) herbal formulation used in clinical practice. It is typically prescribed for conditions related to chronic kidney disease and urinary system disorders within the TCM framework. The formula is composed of multiple herbal ingredients designed to "tonify the kidney" and "consolidate the root," which in TCM theory refers to strengthening renal function and stabilizing bodily essence. While specific mechanisms of action are not defined by Western pharmacology, its use aligns with TCM principles rather than targeting a single molecular pathway or receptor.

Brand names: Tonglin Guben
Other names: Tonglin Guben RecipeTonglin Guben Fang通淋固本方

Beyond the preview

Go deeper on Tonglin Guben.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tonglin Guben.

Explore the full profile